REQUEST A DEMO
Total
USD $0.00
Search more companies

Vietnam Vaccine Joint Stock Company (Vietnam)

Main Activities: Other Ambulatory Health Care Services
Secondary Activities: Pharmaceutical Preparation Manufacturing | Wholesale Trade | Specialty Food Stores
Full name: Vietnam Vaccine Joint Stock Company Profile Updated: February 21, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Established in 2016, VNVC.,JSC specializes in providing vaccines and vaccination services for all ages nationwide. The emergence of the Covid-19 pandemic has made the demand for vaccines higher than ever. Being the first company to bring 30 million doses of AstraZeneca's Covid-19 vaccine to Vietnam shows the company's agility and initiative in responding to market demand. Thanks to that, the subject had impressive business results in 2021. Specifically, net revenue increased by 106% in 2021 and reached VND 7,876 billion compared to VND 3,817 billion in 2020. However, in 2022, when The Covid-19 epidemic was under control, the demand for vaccines decreased, leading to a decrease in the subject's sales. Currently, after 7 years of operation, SC has more than 140 vaccination sites nationwide.

Headquarters
No. 180, Truong Chinh Street, Khuong Thuong Ward
Ha Noi (municipality); Red River Delta; Postal Code: 10000-14000

Contact Details: Purchase the Vietnam Vaccine Joint Stock Company report to view the information.

Website: https://vnvc.vn/

Basic Information
Total Employees:
Purchase the Vietnam Vaccine Joint Stock Company report to view the information.
Outstanding Shares:
Purchase the Vietnam Vaccine Joint Stock Company report to view the information.
Registered Capital:
Purchase the Vietnam Vaccine Joint Stock Company report to view the information.
Incorporation Date:
November 11, 2016
Key Executives
Purchase this report to view the information.
Chairman and General Director
Ownership Details
Purchase this report to view the information.
60%
Purchase this report to view the information.
30%
Purchase this report to view the information.
10%
Subsidiaries
Eco Pharma Joint Stock Company
Company Performance
Financial values in the chart are available after Vietnam Vaccine Joint Stock Company report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency VND. Absolute financial data is included in the purchased report.
Net sales revenue
-7.53%
Total operating revenue
-7.53%
Operating profit (EBIT)
124.15%
Net Profit (Loss) for the Period
123.28%
Total assets
10.65%
Total equity
39.6%
Operating Profit Margin (ROS)
2.63%
Net Profit Margin
2.12%
Return on Equity (ROE)
33.31%
Debt to Equity Ratio
-105.61%
Quick Ratio
0.19%
Cash Ratio
-0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?